Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
11.19
-0.23 (-2.01%)
At close: Mar 13, 2026, 4:00 PM EDT
11.18
-0.01 (-0.09%)
After-hours: Mar 13, 2026, 7:43 PM EDT

Omeros Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
202
Market Cap
793.38M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 201829.87M-34.96M-53.93%
Dec 31, 201764.83M23.21M55.77%
Dec 31, 201641.62M28.11M208.07%
Dec 31, 201513.51M12.97M2,406.31%
Dec 31, 2014539.00K-1.06M-66.31%
Dec 31, 20131.60M-4.42M-73.43%
Dec 31, 20126.02M1.50M33.11%
Dec 31, 20114.52M2.42M114.92%
Dec 31, 20102.11M661.00K45.78%
Dec 31, 20091.44M274.00K23.42%
Dec 31, 20081.17M-753.00K-39.16%
Dec 31, 20071.92M1.52M380.75%
Dec 31, 2006400.00K--
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Fortrea Holdings2.72B
MannKind348.97M
Phathom Pharmaceuticals175.11M
Xencor125.58M
CytomX Therapeutics113.63M
Kura Oncology67.48M
Evommune13.00M
Janux Therapeutics10.00M
Revenue Rankings